| |
Company
Roster
|
|
Total
Insiders : |
32 |
|
|
|
Total
Direct Shares :
|
55,555,683 |
|
|
Total
Indirect Shares :
|
306,534,110 |
| |
%
Held by Insiders:
|
61.3% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Tang Ke |
|
|
0 |
|
0 |
| Yan Wendy Xiaojun |
|
|
0 |
|
0 |
| Yang Jianxin |
Officer |
2016-02-02 |
200,000 |
|
0 |
| Amgen Inc |
10% Owner |
2021-09-10 |
18,943,802 |
|
0 |
| Ball Titus B. |
Principal Accounting Officer |
2024-06-05 |
47,905 |
|
0 |
| Citic Pe Funds Ltd |
10% Owner |
2016-02-08 |
19,601,138 |
2016-02-08 |
0 |
| Yuan Ruirong |
Chief Medical Officer |
2016-02-08 |
130,000 |
2016-02-08 |
0 |
| Li Ji |
EVP and Gl. Head of Bus. Dev. |
2018-02-28 |
475,000 |
2016-05-03 |
0 |
| Peterson Amy C. |
CMO, Immuno-oncology |
2018-12-18 |
194,569 |
2016-08-22 |
0 |
| Chen Timothy Yung-Cheng |
Director |
2021-06-16 |
7,800 |
2018-06-06 |
0 |
| Su Jingshyh S |
Director |
2021-06-16 |
7,800 |
2021-06-16 |
0 |
| Liang Howard |
CFO & Chief Strategy Officer |
2021-06-28 |
1,553,149 |
2016-02-08 |
0 |
| Huang Jane |
CMO, Hematology |
2021-12-14 |
160,055 |
2017-12-04 |
0 |
| Malley Thomas |
Director |
2022-06-22 |
63,774 |
2016-11-23 |
0 |
| Lee Chan Henry |
SVP, General Counsel |
2024-06-05 |
269,399 |
2023-07-31 |
0 |
| Hooper Anthony C |
Director |
2024-06-05 |
53,755 |
2021-06-16 |
0 |
| Dugan Margaret |
Director |
2024-06-05 |
45,955 |
2022-06-22 |
0 |
| Yi Qingqing |
Director |
2024-06-05 |
45,955 |
2018-06-06 |
0 |
| Brandicourt Olivier |
Director |
2024-06-05 |
16,341 |
2024-06-05 |
0 |
| Riva Alessandro |
Director |
2024-06-05 |
45,955 |
2022-06-22 |
0 |
| Sanders Corazon (corsee) D. |
Director |
2024-06-05 |
46,241 |
2021-06-16 |
0 |
| Wang Julia Aijun |
Chief Financial Officer |
2024-06-05 |
456,326 |
2021-07-01 |
0 |
| Wu Xiaobin |
President, COO & GM China |
2024-06-05 |
1,281,214 |
2024-06-05 |
4,000 |
| Glazer Donald W. |
Director |
2024-06-05 |
2,718,464 |
2019-03-14 |
38,160 |
| Wang Lai |
Global Head of R&D |
2024-06-05 |
1,768,962 |
2024-06-05 |
58,188 |
| Wang Xiaodong |
Chair, Scientific Advisory Brd, Director |
2024-06-05 |
5,568,430 |
2024-06-05 |
5,186,590 |
| Merck Sharp & Dohme Research Gmbh |
10% Owner |
2016-02-08 |
0 |
2016-02-08 |
7,942,314 |
| Baker Brothers Life Sciences Lp |
Director, 10% Owner |
2023-11-14 |
20,838 |
2023-11-14 |
9,878,124 |
| Baker Julian |
|
2024-06-05 |
20,838 |
2024-06-05 |
10,694,996 |
| Oyler John |
Chief Executive Officer, Director |
2024-06-05 |
1,812,018 |
2024-06-05 |
46,190,763 |
| 14159, L.p. |
Director, 10% Owner |
2016-02-08 |
0 |
2016-11-18 |
83,652,734 |
| Hillhouse Capital Management, Ltd. |
10% Owner |
2016-02-08 |
0 |
2023-06-14 |
142,888,241 |
|
1.24 (0.79%) 
